Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BNC
CEA Industries
$2.61
+2.8%
$2.59
$1.84
$29.39
$107.25M0.56328,879 shs74,280 shs
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
$2.06
+4.4%
$2.47
$1.08
$9.08
$158.48M1.45844,180 shs506,677 shs
Solana Company stock logo
HSDT
Solana
$1.75
-3.1%
$1.67
$1.19
$25.50
$101.89M1.01346,271 shs83,656 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$2.72
-4.1%
$2.91
$2.34
$15.00
$41.16M2.53434,227 shs140,155 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BNC
CEA Industries
+0.79%+10.43%-12.11%-6.96%+253,999,900.00%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
0.00%+5.91%-14.35%-45.58%+196,999,900.00%
Solana Company stock logo
HSDT
Solana
+3.45%+7.14%+2.86%-21.74%-70.15%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
+5.20%+5.99%-4.39%-15.77%-59.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BNC
CEA Industries
$2.61
+2.8%
$2.59
$1.84
$29.39
$107.25M0.56328,879 shs74,280 shs
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
$2.06
+4.4%
$2.47
$1.08
$9.08
$158.48M1.45844,180 shs506,677 shs
Solana Company stock logo
HSDT
Solana
$1.75
-3.1%
$1.67
$1.19
$25.50
$101.89M1.01346,271 shs83,656 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$2.72
-4.1%
$2.91
$2.34
$15.00
$41.16M2.53434,227 shs140,155 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BNC
CEA Industries
+0.79%+10.43%-12.11%-6.96%+253,999,900.00%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
0.00%+5.91%-14.35%-45.58%+196,999,900.00%
Solana Company stock logo
HSDT
Solana
+3.45%+7.14%+2.86%-21.74%-70.15%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
+5.20%+5.99%-4.39%-15.77%-59.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BNC
CEA Industries
1.00
SellN/AN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
1.00
SellN/AN/A
Solana Company stock logo
HSDT
Solana
2.50
Moderate Buy$3.50100.57% Upside
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
2.00
Hold$7.20165.19% Upside

Current Analyst Ratings Breakdown

Latest HYPD, CNTN, HSDT, and BNC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Boost Price TargetOverweight$6.60 ➝ $7.10
8/12/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
DowngradeHoldStrong Sell
8/11/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Reiterated RatingBuy$7.30
7/28/2026
BNC
CEA Industries
UpgradeSell (D)Sell (D+)
7/17/2026
Solana Company stock logo
HSDT
Solana
Reiterated RatingSell (E+)
7/15/2026
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
DowngradeSell (D-)Sell (E+)
7/14/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
UpgradeStrong SellHold
7/6/2026
BNC
CEA Industries
Reiterated RatingSell (D)
7/1/2026
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
UpgradeSell (E+)Sell (D-)
7/1/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Boost Price TargetOverweight$4.00 ➝ $6.60
6/24/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
UpgradeSell (E+)Sell (D-)
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BNC
CEA Industries
$29.33M3.67$2.81 per share0.93$7.11 per share0.37
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/AN/AN/AN/A$10.92 per shareN/A
Solana Company stock logo
HSDT
Solana
$6.02M16.93N/AN/A$6.88 per share0.25
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$810K50.81N/AN/A$4.73 per share0.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BNC
CEA Industries
$115.26M$5.650.46N/AN/A392.91%81.62%67.22%N/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
-$35.92M-$1.15N/AN/AN/AN/A-31.50%-24.72%N/A
Solana Company stock logo
HSDT
Solana
-$40.89M-$109.67N/AN/AN/A-1,427.15%-67.57%-24.09%8/14/2026 (Estimated)
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-$45.31M-$9.95N/A2.54N/A416.56%-13.93%-11.60%N/A

Latest HYPD, CNTN, HSDT, and BNC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/A-$0.08N/A-$0.08N/AN/A
8/14/2026Q2 2026
Solana Company stock logo
HSDT
Solana
-$0.02N/AN/AN/A$3.50 millionN/A
8/13/2026Q2 2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/A$0.92N/A$0.92N/A$0.36 million
6/23/2026Q4 2026
BNC
CEA Industries
N/A$6.20N/A$6.20N/A$7.35 million
5/15/2026Q1 2026
Solana Company stock logo
HSDT
Solana
-$0.34-$1.30-$0.96-$1.30$3.40 million$3.62 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BNC
CEA Industries
N/AN/AN/AN/AN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/AN/AN/AN/AN/A
Solana Company stock logo
HSDT
Solana
N/AN/AN/AN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BNC
CEA Industries
N/A
1.18
0.72
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
N/A
37.76
37.76
Solana Company stock logo
HSDT
Solana
N/A
9.90
9.90
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
0.12
1.97
1.97

Institutional Ownership

CompanyInstitutional Ownership
BNC
CEA Industries
N/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
1.16%
Solana Company stock logo
HSDT
Solana
18.63%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
25.84%

Insider Ownership

CompanyInsider Ownership
BNC
CEA Industries
2.70%
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
3.34%
Solana Company stock logo
HSDT
Solana
14.40%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
BNC
CEA Industries
3041.17 million40.06 millionN/A
Hillstream Biopharma Inc. stock logo
CNTN
Hillstream Biopharma
277.12 million74.55 millionN/A
Solana Company stock logo
HSDT
Solana
3058.39 million49.98 millionNot Optionable
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
4015.16 million14.02 millionNo Data

Recent News About These Companies

Chardan Capital Reiterates Buy Rating for Hyperion DeFi (NASDAQ:HYPD)
Hyperion DeFi, Inc. Common Stock
Hyperion Gains on Blockdaemon Hookup
Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets

New MarketBeat Followers Over Time

Media Sentiment Over Time

CEA Industries NASDAQ:BNC

$2.61 +0.07 (+2.83%)
As of 03:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CEA Industries Inc. provides technology, engineering, and other services to the controlled environment agriculture (CEA) industry worldwide. It offers floor plans and architectural design for cultivation facilities; licensed mechanical, electrical, and plumbing engineering services for commercial scale environmental control systems that are specific to cultivation facilities; and process cooling systems and other climate control systems. The company also provides air handling equipment and systems; LED lighting; benching and racking solutions for indoor cultivation; automation and control devices, systems, and technologies for environmental, lighting, and climate control applications; and preventive maintenance services for CEA facilities. It serves commercial, as well as state- and provincial-regulated CEA growers. The company was formerly known as Surna Inc. and changed its name to CEA Industries Inc. in November 2021. CEA Industries Inc. was founded in 2006 and is headquartered in Louisville, Colorado.

Hillstream Biopharma stock logo

Hillstream Biopharma NASDAQ:CNTN

$2.06 +0.09 (+4.37%)
As of 03:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.

Solana stock logo

Solana NASDAQ:HSDT

$1.74 -0.06 (-3.06%)
As of 03:19 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Hyperion DeFi stock logo

Hyperion DeFi NASDAQ:HYPD

$2.72 -0.12 (-4.06%)
As of 03:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.